Risk of lymphoma subtypes after solid organ transplantation in the United States
Authors:
- C A ClarkeCCC A Clarke
- L M MortonLML M Morton
- C LynchCLC Lynch
- R M PfeifferRPR M Pfeiffer
- E C HallEHE C Hall
- T M GibsonTGT M Gibson
- D D WeisenburgerDWD D Weisenburger
- O Martínez-MazaOMO Martínez-Maza
- S K HussainSHS K Hussain
- J YangJYJ Yang
- E T ChangECE T Chang
- E A EngelsEEE A Engels
Open Access
- 11 June 2013
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 109 (1) , 280-288
Abstract
Solid organ transplant recipients have high risk of lymphomas, including non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL). A gap in our understanding of post-transplant lymphomas involves the spectrum and associated risks of their many histologic subtypes. We linked nationwide data on solid organ transplants from the US Scientific Registry of Transplant Recipients (1987-2008) to 14 state and regional cancer registries, yielding 791 281 person-years of follow-up for 19 distinct NHL subtypes and HL. We calculated standardised incidence ratios (SIRs) and used Poisson regression to compare SIRs by recipient age, transplanted organ, and time since transplantation. The risk varied widely across subtypes, with strong elevations (SIRs 10-100) for hepatosplenic T-cell lymphoma, Burkitt's lymphoma, NK/T-cell lymphoma, diffuse large B-cell lymphoma, and anaplastic large-cell lymphoma (both systemic and primary cutaneous forms). Moderate elevations (SIRs 2-4) were observed for HL and lymphoplasmacytic, peripheral T-cell, and marginal zone lymphomas, but SIRs for indolent lymphoma subtypes were not elevated. Generally, SIRs were highest for younger recipients (<20 years) and those receiving organs other than kidneys. Transplant recipients experience markedly elevated risk of a distinct spectrum of lymphoma subtypes. These findings support the aetiologic relevance of immunosuppression for certain subtypes and underscore the importance of detailed haematopathologic workup for transplant recipients with suspected lymphoma.Keywords
This publication has 44 references indexed in Scilit:
- T-Cell Non-Hodgkin's Lymphomas Reported to the FDA AERS With Tumor Necrosis Factor-Alpha (TNF-α) Inhibitors: Results of the REFURBISH StudyAmerican Journal of Gastroenterology, 2013
- Spectrum of Cancer Risk Among US Solid Organ Transplant RecipientsJAMA, 2011
- InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directionsBlood, 2010
- Hodgkin Lymphoma Among US Solid Organ Transplant RecipientsTransplantation, 2010
- Risk factors for early‐onset and late‐onset post‐transplant lymphoproliferative disorder in kidney recipients in the United StatesAmerican Journal of Hematology, 2010
- Increased Risk for Lymphoid and Myeloid Neoplasms in Elderly Solid-Organ Transplant RecipientsCancer Epidemiology, Biomarkers & Prevention, 2010
- Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapyAIDS, 2009
- Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantationBlood, 2009
- Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern EuropeEuropean Journal of Cancer, 2007
- Post-Transplant Lymphoproliferative Disorders Occurring After Renal Transplantation in Adults: Report of 230 Cases From the French RegistryAmerican Journal of Transplantation, 2006